Videos | Channels | Search |
What is it with Ireland's healthcare companies? In the past week alone, we've heard that the US giant Medtronic wants to buy Dublin based Covidien for USD 43 billion. On Tuesday it was reported that Citi has been hired by the Irish pharma company, Shire, as it's expecting takeover bids. It raises the question, should we all be investing in Irish pharmaceutical and biotech companies?
02:01 minutes
Tags: astra, astrazeneca, billions, biotech, cash, cash flow, citi, corporation tax, covidien, deal, deals, dublin, emerald isle, equities, equity, equity strategy, euros, ftse, growth prospects, healthcare, healthcare ireland, invest in ireland, investing, ireland, irish, irish health, irish healthcare, irish tax laws, london, m and a, m and a trends, m&a, m&a trends, margins, medtronic, multinationals, news, owen thomas, peter garnry, pfizer, pharma, pharmaceutical, profit, reapatriation, saxo, saxo bank, saxo tv, saxotv, shares, shire, stock exchange, stock picks, stocks, stocks irish, takeover, takeovers, tax, tax laws, trading, tradingfloor.com, trend, trends, tv, us, us healthcare, us multinationals, us pharma, valuations, video